BIVI
Closed
Biovie Inc
0.931
+0.006 (+0.65%)
Last Update: 01 Jul 2025 23:05:00
Yesterday: 0.925
Day's Range: 0.88 - 0.96
Send
sign up or login to leave a comment!
When Written:
8.08
Biovie Inc. is a clinical-stage biotechnology company that is focused on developing and commercializing innovative drug therapies for rare and orphan diseases. The company's lead drug candidate is BIV201, which is being developed for the treatment of refractory hypotension, a life-threatening condition that affects patients with severe sepsis and septic shock. Biovie is also developing other drug candidates for the treatment of rare and orphan diseases, including pulmonary arterial hypertension and acute respiratory distress syndrome. The company is headquartered in Beverly, Massachusetts, and was founded in 2010.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








